Maria E. Vega

Maria E. Vega

Auto-generated profile, based on publicly available information

Maria E. Vega

Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in Cancer Cell
Verified
Journal Article
Closed access
DSDouglas B. Stairs
Douglas B. Stairs
LBLauren J. Bayne
Lauren J. Bayne
BRBen Rhoades
Ben Rhoades
MVMaria E. Vega
Maria E. Vega
TWTodd J. Waldron
Todd J. Waldron
ARAnil Rustgi
Anil Rustgi

12 January 2012 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
JKJiri Kalabis
Jiri Kalabis
GWGabrielle S Wong
Gabrielle S Wong
MVMaria E Vega
Maria E Vega
MNMitsuteru Natsuizaka
Mitsuteru Natsuizaka
ERErle S Robertson
Erle S Robertson
ARAnil Rustgi
Anil Rustgi

26 August 2010 in Blood
Verified
Journal Article
Open access
PDF file
PDPriya H. Dedhia
Priya H. Dedhia
KKKaren Keeshan
Karen Keeshan
SUSacha Uljon
Sacha Uljon
LXLanwei Xu
Lanwei Xu
MVMaria E. Vega
Maria E. Vega
WPWarren S. Pear
Warren S. Pear
Trib1, Trib2, and Trib3 are mammalian homologs of Tribbles, an evolutionarily conserved Drosophila protein family that mediates protein degradation. Tribbles proteins function as adapters to recruit E3 ubiquitin ligases and enhance ubiquitylation of the target protein to promote its degradation. Increased Trib1 and Trib2 mRNA expression occurs in human myeloid leukemia and induces acute myeloid leukemia in mice, whereas Trib3 has not been associated with leukemia. Given the high degree of structural conservation among Tribbles family members, we directly compared the 3 mammalian Tribbles in hematopoietic cells by reconstituting mice with hematopoietic stem cells retrovirally expressing these proteins. All mice receiving Trib1 or Trib2 transduced hematopoietic stem cells developed acute myeloid leukemia, whereas Trib3 mice did not. Our previous data indicated that Trib2-mediated degradation of the transcription factor, CCAAT/enhancer-binding protein-alpha (C/EBPα), is important for leukemogenesis. Similar to Trib2, Trib1 induced C/EBPα degradation and inhibited its function. In contrast, Trib3 failed to inactivate or promote efficient degradation of C/EBPα. These data reveal that the 3 Tribbles homologs differ in their ability to promote degradation of C/EBPα, which account for their differential ability to induce leukemia.

12 May 2010 in Cancer Research
Verified
Journal Article
Closed access
PDF file
SOShinya Ohashi
Shinya Ohashi
MNMitsuteru Natsuizaka
Mitsuteru Natsuizaka
GWGabrielle S. Wong
Gabrielle S. Wong
CMCarmen Z. Michaylira
Carmen Z. Michaylira
KGKatharine D. Grugan
Katharine D. Grugan
HNHiroshi Nakagawa
Hiroshi Nakagawa
Transforming growth factor-β (TGF-β) is a potent inducer of epithelial to mesenchymal transition (EMT). However, it remains elusive about which molecular mechanisms determine the cellular capacity to undergo EMT in response to TGF-β. We have found that both epidermal growth factor receptor (EGFR) overexpression and mutant p53 tumor suppressor genes contribute to the enrichment of an EMT-competent cellular subpopulation among telomerase-immortalized human esophageal epithelial cells during malignant transformation. EGFR overexpression triggers oncogene-induced senescence, accompanied by the induction of cyclin-dependent kinase inhibitors p15INK4B, p16INK4A, and p21. Interestingly, a subpopulation of cells emerges by negating senescence without loss of EGFR overexpression. Such cell populations express increased levels of zinc finger E-box binding (ZEB) transcription factors ZEB1 and ZEB2, and undergo EMT on TGF-β stimulation. Enrichment of EMT-competent cells was more evident in the presence of p53 mutation, which diminished EGFR-induced senescence. RNA interference directed against ZEB resulted in the induction of p15INK4B and p16INK4A, reactivating the EGFR-dependent senescence program. Importantly, TGF-β–mediated EMT did not take place when cellular senescence programs were activated by either ZEB knockdown or the activation of wild-type p53 function. Thus, senescence checkpoint functions activated by EGFR and p53 may be evaded through the induction of ZEB, thereby allowing the expansion of an EMT-competent unique cellular subpopulation, providing novel mechanistic insights into the role of ZEB in esophageal carcinogenesis. Cancer Res; 70(10); 4174–84. ©2010 AACR.

2 December 2010 in Blood
Verified
Journal Article
Closed access
PDF file
KKKaren Keeshan
Karen Keeshan
WBWill Bailis
Will Bailis
PDPriya H. Dedhia
Priya H. Dedhia
MVMaria E. Vega
Maria E. Vega
OSOlga Shestova
Olga Shestova
WPWarren S. Pear
Warren S. Pear
Tribbles homolog 2 (Trib2) is a pseudokinase that induces acute myelogenous leukemia (AML) in mice and is highly expressed in a subset of human AML. Trib2 has 3 distinct regions, a proline-rich N-terminus, a serine/threonine kinase homology domain, and a C-terminal constitutive photomorphogenesis 1 (COP1)–binding domain. We performed a structure-function analysis of Trib2 using in vitro and in vivo assays. The N-terminus was not required for Trib2-induced AML. Deletion or mutation of the COP1-binding site abrogated the ability of Trib2 to degrade CCAAT/enhancer-binding protein-α (C/EBP-α), block granulocytic differentiation, and to induce AML in vivo. Furthermore, COP1 knockdown inhibited the ability of Trib2 to degrade C/EBP-α, showing that it is important for mediating Trib2 activity. We also show that the Trib2 kinase domain is essential for its function. Trib2 contains variant catalytic loop sequences, compared with conventional kinases, that we show are necessary for Trib2 activity. The kinase domain mutants bind, but cannot efficiently degrade, C/EBP-α. Together, our data demonstrate that Trib2 can bind both COP1 and C/EBP-α, leading to degradation of C/EBP-α. Identification of the functional regions of Trib2 that are essential to its oncogenic role provides the basis for developing inhibitors that will block Trib functions in cancer.

15 December 2014 in Cell Cycle
Verified
Journal Article
Closed access
MVMaria E Vega
Maria E Vega
VGVéronique Giroux
Véronique Giroux
MNMitsuteru Natsuizaka
Mitsuteru Natsuizaka
MLMingen Liu
Mingen Liu
AKAndres J Klein-Szanto
Andres J Klein-Szanto
ARAnil Rustgi
Anil Rustgi
Barrett's esophagus (BE) is defined as an incomplete intestinal metaplasia characterized generally by the presence of columnar and goblet cells in the formerly stratified squamous epithelium of the esophagus. BE is known as a precursor for esophageal adenocarcinoma. Currently, the cell of origin for human BE has yet to be clearly identified. Therefore, we investigated the role of Notch signaling in the initiation of BE metaplasia. Affymetrix gene expression microarray revealed that BE samples express decreased levels of Notch receptors (NOTCH2 and NOTCH3) and one of the the ligands (JAG1). Furthermore, BE tissue microarray showed decreased expression of NOTCH1 and its downstream target HES1. Therefore, Notch signaling was inhibited in human esophageal epithelial cells by expression of dominant-negative-Mastermind-like (dnMAML), in concert with MYC and CDX1 overexpression. Cell transdifferentiation was then assessed by 3D organotypic culture and evaluation of BE-lineage specific gene expression. Notch inhibition promoted transdifferentiation of esophageal epithelial cells toward columnar-like cells as demonstrated by increased expression of columnar keratins (K8, K18, K19, K20) and glandular mucins (MUC2, MUC3B, MUC5B, MUC17) and decreased expression of squamous keratins (K5, K13, K14). In 3D culture, elongated cells were observed in the basal layer of the epithelium with Notch inhibition. Furthermore, we observed increased expression of KLF4, a potential driver of the changes observed by Notch inhibition. Interestingly, knockdown of KLF4 reversed the effects of Notch inhibition on BE-like metaplasia. Overall, Notch signaling inhibition promotes transdifferentiation of esophageal cells toward BE-like metaplasia in part via upregulation of KLF4. These results support a novel mechanism through which esophageal epithelial transdifferentiation promotes the evolution of BE.